Public Profile

Jianmin Pharmaceutical

Jianmin Pharmaceutical Co., Ltd., commonly referred to as Jianmin Pharma, is a prominent player in the pharmaceutical industry, headquartered in China (CN). Established in the early 1990s, the company has made significant strides in the development and production of a diverse range of pharmaceutical products, including traditional Chinese medicine and modern therapeutics. With a strong operational presence across various regions in China, Jianmin Pharma is dedicated to enhancing healthcare through innovative solutions. The company is renowned for its unique formulations and commitment to quality, which have positioned it as a trusted name in the market. Notable achievements include several industry awards and recognitions for excellence in research and development, underscoring its role as a leader in the pharmaceutical sector.

DitchCarbon Score

How does Jianmin Pharmaceutical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

20

Industry Average

Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

9

Industry Benchmark

Jianmin Pharmaceutical's score of 20 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Jianmin Pharmaceutical's reported carbon emissions

Jianmin Pharmaceutical, headquartered in CN, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This lack of information suggests that Jianmin Pharmaceutical may still be in the early stages of developing a comprehensive climate strategy or reporting framework. As the pharmaceutical industry increasingly prioritises sustainability, it will be essential for Jianmin to establish clear emissions reduction goals and commitments to align with global climate standards.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Jianmin Pharmaceutical's primary industry is Other business services (74), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Jianmin Pharmaceutical is headquartered in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Jianmin Pharmaceutical is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Business Services

CDP

Benson Hill

US
Business Services
Updated 10 days ago

Nippon Weston Coltd

JP
Business Services
Updated 11 days ago

Productos del Tropico S.A.S

DO
Business Services
Updated 11 days ago

NIM

GB
Business Services
Updated 11 days ago

Global Infotech Corporation

US
Business Services
Updated 3 days ago

Sitecore

DK
Business Services
Updated 11 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers